Cancer Family
Pancreaticobiliary Neoplasm
CI-CAN-00000309Explore in graph →
Non-malignant1,205 active trials11 approved drugs92 evidence items
- NCIt
- C223357
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000309Explore in graph →
Clinical trials
5,005 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00068575 | Chemotherapy, Interferon Alfa, and Radiation Therapy in Treating Patients Who Have Undergone Surgery For Pancreatic Cancer | completed | Phase 2 | 29 | M.D. Anderson Cancer CenterOTHER | 1 | Feb 15, 2012 | clinicaltrials |
| NCT00082862 | Cisplatin, Metronomic Low-Dose Interferon Alfa, Gemcitabine, and Fever-Range Whole-Body Hyperthermia in Treating Patients With Inoperable or Metastatic Pancreatic Cancer | unknown | Phase 2 | 48 | The University of Texas Health Science Center, HoustonOTHER | 1 |
| Feb 13, 2012 |
| clinicaltrials |
| NCT00913198 | A Study of CP-4126 in Patients With Advanced Pancreatic Cancer | completed | Phase 2 | 21 | Clavis PharmaINDUSTRY | 2 | Feb 10, 2012 | clinicaltrials |
| NCT01525719 | Single Arm Study of RAD001 as Monotherapy in Treatment in Advanced Cholangiocarcinoma(CRAD001T) | unknown | Phase 2 | 40 | Ratchavithi HospitalOTHER_GOV | 0 | Feb 3, 2012 | clinicaltrials |
| NCT00966706 | Cisplatin, Capecitabine, Gemcitabine and Epirubicin or Docetaxel for Patients With Stage III or IV Pancreatic Cancer(PACT-9) | completed | Phase 2 | 105 | IRCCS San RaffaeleOTHER | 1 | Feb 1, 2012 | clinicaltrials |
| NCT00967291 | Mitomycin C and Ifosfamide in Treating Patients With Metastatic Pancreatic Cancer(PACT-11) | terminated | Phase 2 | 21 | IRCCS San RaffaeleOTHER | 1 | Feb 1, 2012 | clinicaltrials |
| NCT00967603 | Maintenance Therapy With Sunitinib or Observation in Metastatic Pancreatic Cancer(PACT-12) | completed | Phase 2 | 56 | IRCCS San RaffaeleOTHER | 1 | Feb 1, 2012 | clinicaltrials |
| NCT00898287 | Safety and Efficacy Study of P276-00 in Combination With Gemcitabine in Patients With Advanced Pancreatic Cancer(SAVIOR) | completed | Phase 1 / Phase 2 | 23 | Piramal Enterprises LimitedINDUSTRY | 1 | Jan 20, 2012 | clinicaltrials |
| NCT00960284 | Gemcitabine or Combination Chemotherapy Followed by Chemoradiation for Stage IB, II, or III Pancreatic Cancer(PACT-7) | completed | Phase 2 / Phase 3 | 102 | IRCCS San RaffaeleOTHER | 1 | Jan 13, 2012 | clinicaltrials |
| NCT00084942 | Gemcitabine and Capecitabine in Treating Patients With Advanced and/or Inoperable Cholangiocarcinoma or Carcinoma of the Gallbladder | completed | Phase 2 | — | Roswell Park Cancer InstituteOTHER | 1 | Jan 12, 2012 | clinicaltrials |
| NCT00111904 | Paclitaxel in Treating Patients With Unresectable Locally Advanced or Metastatic Pancreatic Cancer | completed | Phase 2 | 43 | TheradexINDUSTRY | 1 | Dec 14, 2011 | clinicaltrials |
| NCT00786006 | Randomized Phase II Study of FOLFOX Versus FOLFIRI.3 in Gemcitabine-refractory Pancreatic Cancer | completed | Phase 2 | 61 | Asan Medical CenterOTHER | 1 | Dec 6, 2011 | clinicaltrials |
| NCT01268384 | Neoadjuvant FDR GX in Locally Advanced Pancreatic Cancer | completed | Phase 2 | 43 | Asan Medical CenterOTHER | 1 | Dec 6, 2011 | clinicaltrials |
| NCT00673504 | First-Line Gemcitabine Chemotherapy With Our Without Sunitinib In Advanced or Metastatic Pancreatic Cancer | completed | Phase 2 | 105 | Central European Society for Anticancer Drug ResearchOTHER | 2 | Dec 1, 2011 | clinicaltrials |
| NCT01016639 | Study of Capecitabine and Oxaliplatin in Combination With Radiotherapy in Patients With Unresectable Gastro-Intestinal Cancer(CORGI) | completed | Phase 1 / Phase 2 | 106 | Lund University HospitalOTHER | 1 | Oct 17, 2011 | clinicaltrials |
| NCT00795977 | Preoperative Intratumor Dendritic Cells Injection Immunotherapy for Patients With Pancreatic Cancer | unknown | Phase 1 / Phase 2 | 20 | Fukushima Medical UniversityOTHER | 1 | Sep 8, 2011 | clinicaltrials |
| NCT00568646 | Phase 2 Study of Oral MKC-1 in Patients With Unresectable or Metastatic Pancreatic Cancer | completed | Phase 2 | 33 | CASI pharmaceuticals, Inc.INDUSTRY | 1 | Aug 4, 2011 | clinicaltrials |
| NCT00683085 | Human Leukocyte Antigen-A*02:01-restricted Tumor Vessel Specific Peptide Vaccination for Advanced Pancreatic Cancer | terminated | Phase 1 / Phase 2 | 2 | Tokyo UniversityOTHER | 1 | Jul 22, 2011 | clinicaltrials |
| NCT01396668 | Fixed Dose Rate Gemcitabine and Cisplatin Followed by Chemoradiation for Locally Advanced Pancreatic Cancer | completed | Phase 2 | 35 | Seoul National University HospitalOTHER | 1 | Jul 19, 2011 | clinicaltrials |
| NCT01396681 | Adjuvant Gemcitabine and Cisplatin Followed by Chemoradiation for Resected Pancreatic Cancer | completed | Phase 2 | 70 | Seoul National University HospitalOTHER | 1 | Jul 19, 2011 | clinicaltrials |
| NCT00268840 | The Efficacy and Safety of Gemcitabine in Combination With Docetaxel to Treat Pancreatic or Biliary Cancer | completed | Phase 2 | 45 | ARCAGY/ GINECO GROUPOTHER | 1 | Jun 30, 2011 | clinicaltrials |
| NCT00514163 | GEM vs GEM+TS-1 for Advanced Pancreatic Cancer | completed | Phase 2 | 110 | Japan Clinical Cancer Research OrganizationOTHER | 1 | Jun 28, 2011 | clinicaltrials |
| NCT00810953 | A Safety Study Using Pentamidine in Patients With Pancreatic Cancer Undergoing Standard Therapy | completed | Phase 1 / Phase 2 | 10 | Oncozyme Pharma Inc.INDUSTRY | 1 | Jun 28, 2011 | clinicaltrials |
| NCT00004087 | Radiolabeled Monoclonal Antibody Therapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Metastatic or Recurrent Colorectal Cancer or Pancreatic Cancer | completed | Phase 1 / Phase 2 | 15 | Garden State Cancer Center at the Center for Molecular Medicine and ImmunologyOTHER | 1 | Jun 22, 2011 | clinicaltrials |
| NCT01372735 | Trial of Neoadjuvant Short Course IMRT Followed by Surgery and IORT for Resectable Pancreatic Cancer(NEOPANC) | unknown | Phase 1 / Phase 2 | 46 | University Hospital HeidelbergOTHER | 1 | Jun 14, 2011 | clinicaltrials |
| NCT00504998 | Safety/Efficacy Study of Rexin-G to Treat Pancreatic Cancer | completed | Phase 1 / Phase 2 | 20 | Epeius BiotechnologiesINDUSTRY | 1 | Jun 10, 2011 | clinicaltrials |
| NCT00550004 | Phase II Study to Evaluate Efficacy and Safety of RP101 in Combination With Gemcitabine(RP101) | terminated | Phase 2 | 153 | SciClone PharmaceuticalsINDUSTRY | 13 | Jun 8, 2011 | clinicaltrials |
| NCT00326911 | Cetuximab and Bevacizumab With or Without Gemcitabine to Treat Metastatic Pancreatic Cancer | terminated | Phase 2 | 61 | Eli Lilly and CompanyINDUSTRY | 1 | May 25, 2011 | clinicaltrials |
| NCT00060502 | A Study of the Safety and Effectiveness of Infliximab (Remicade) in Patients With Pancreatic Cancer Related Cachexia | completed | Phase 2 | 73 | Centocor, Inc.INDUSTRY | 0 | May 17, 2011 | clinicaltrials |
| NCT01333631 | Valproic Acid With Chemoradiotherapy for Pancreatic Cancer | unknown | Phase 2 | 20 | Soroka University Medical CenterOTHER | 0 | Apr 12, 2011 | clinicaltrials |
| NCT01333332 | Radiotherapy With Chemotherapy as Neoadjuvant Therapy of Resectable and Borderline Resectable Pancreas Cancer | unknown | Phase 2 | 35 | University of VirginiaOTHER | 1 | Apr 11, 2011 | clinicaltrials |
| NCT00003332 | Combination Chemotherapy Followed by Chemotherapy and Radiation Therapy and/or Surgery in Treating Patients Who Have Pancreatic Cancer | completed | Phase 1 / Phase 2 | 36 | NYU Langone HealthOTHER | 1 | Mar 28, 2011 | clinicaltrials |
| NCT00003125 | Vaccine Therapy, Interleukin-2, and Sargramostim in Treating Patients With Advanced Tumors | completed | Phase 2 | 24 | Georgetown UniversityOTHER | 1 | Mar 24, 2011 | clinicaltrials |
| NCT01317069 | A Randomized, Open, Prospective Clinical Research of Fluorouracil Implant to Improve Surgical Gallbladder Cancer and Bile Duct Cancer | unknown | Phase 2 | 100 | Simcere Pharmaceutical Co., LtdOTHER | 1 | Mar 17, 2011 | clinicaltrials |
| NCT00178763 | Hyperthermia With Chemotherapy for Locally Advanced or Metastatic Pancreas Cancer(FR-WB-TT) | unknown | Phase 2 | 36 | The University of Texas Health Science Center, HoustonOTHER | 1 | Mar 3, 2011 | clinicaltrials |
| NCT00005594 | ISIS 2503 in Treating Patients With Advanced Cancer of the Pancreas | completed | Phase 2 | 4 | University of Alabama at BirminghamOTHER | 1 | Jan 4, 2011 | clinicaltrials |
| NCT00242190 | Gemcitabine, Oxaliplatin and Radiation Therapy in Pancreatic Cancer | completed | Phase 1 / Phase 2 | 40 | University of Michigan Rogel Cancer CenterOTHER | 1 | Nov 15, 2010 | clinicaltrials |
| NCT00192712 | Irinotecan, Gemcitabine and Radiation Therapy for Pancreatic Cancer | completed | Phase 2 / Phase 3 | 20 | Rambam Health Care CampusOTHER | 1 | Nov 10, 2010 | clinicaltrials |
| NCT00192842 | Gemcitabine With Curcumin for Pancreatic Cancer | completed | Phase 2 | 17 | Rambam Health Care CampusOTHER | 0 | Sep 22, 2010 | clinicaltrials |
| NCT00873353 | Trial to Evaluate the Efficacy and Safety of Tarceva and Capecitabine in Advanced Pancreatic Cancer Patients(XELTA) | completed | Phase 2 | 32 | Grupo Gallego de Investigaciones OncologicasOTHER | 1 | Aug 18, 2010 | clinicaltrials |
| NCT00005997 | Rebeccamycin Analogue in Treating Patients With Advanced Liver and/or Biliary Cancer | terminated | Phase 2 | 72 | Case Comprehensive Cancer CenterOTHER | 1 | Jun 11, 2010 | clinicaltrials |
| NCT00233415 | Cyberknife Radiosurgery for Locally Advanced Pancreatic Cancer | completed | Phase 2 | 100 | Stanford UniversityOTHER | 1 | Jun 2, 2010 | clinicaltrials |
| NCT00761241 | Borderline Resectable Pancreatic Cancer: Gemcitabine/Docetaxel and Oxaliplatin Based Chemo/RT | completed | Phase 2 | 40 | Benaroya Research InstituteOTHER | 1 | May 26, 2010 | clinicaltrials |
| NCT00303927 | Capecitabine as Second-Line Therapy in Treating Patients With Stage IV Pancreatic Cancer Who Have the Thymidylate Synthase Gene | completed | Phase 2 | 65 | Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER | 2 | Mar 19, 2010 | clinicaltrials |
| NCT00690300 | Docetaxel Plus Oxaliplatin as Therapy in Patients With Pancreatic Cancer | unknown | Phase 2 | 44 | University of UlmOTHER | 1 | Mar 3, 2010 | clinicaltrials |
| NCT01063192 | A Study of Locally Advanced Pancreatic Cancer | unknown | Phase 2 | 73 | National Health Research Institutes, TaiwanOTHER | 0 | Feb 5, 2010 | clinicaltrials |
| NCT00744640 | Gemcitabine, Oxaliplatin and Capecitabine for Advanced Pancreatic Carcinoma(GEMOXEL) | completed | Phase 1 / Phase 2 | 46 | University Hospital, Basel, SwitzerlandOTHER | 1 | Jan 12, 2010 | clinicaltrials |
| NCT01039181 | Calcitriol in Advanced Intrahepatic Cholangiocarcinoma | unknown | Phase 2 | 28 | National Science and Technology Development Agency, ThailandOTHER_GOV | 1 | Dec 24, 2009 | clinicaltrials |
| NCT00125021 | Tarceva and Capecitabine for Pancreatic Cancer | completed | Phase 2 | 32 | Dana-Farber Cancer InstituteOTHER | 1 | Nov 2, 2009 | clinicaltrials |
| NCT00137761 | Docetaxel in Combination With Iressa in Previously Treated Patients With Pancreatic Cancer | completed | Phase 2 | 32 | Dana-Farber Cancer InstituteOTHER | 1 | Nov 2, 2009 | clinicaltrials |
Data updated 23 days agoSource updated Feb 15, 2012source: clinicaltrials